Showing 1 - 10 of 52,573
The New Zealand Biotechnology sector is worthy of study for several reasons. While there is a large and growing … international literature on economic aspects of biotechnology innovation these studies concentrate on the United States and Europe …. The New Zealand biotechnology sector may be expected to develop along a different trajectory as a consequence of a …
Persistent link: https://www.econbiz.de/10005404213
While there is a large and growing international literature on economic aspects of biotechnology innovation (e.g. work … Zealand biotechnology industry may be expected to develop along a different trajectory as a consequence of a markedly … biotech patent data and results from the New Zealand and Canadian biotechnology surveys. The paper then focuses on factors …
Persistent link: https://www.econbiz.de/10005634962
areas where New Zealand may be able to develop a new comparative advantage. One such area is biotechnology, which would …). This paper aims to fill some of the gaps in our knowledge of biotechnology and innovation processes in New Zealand. It is … based on the 1998/99 survey of modern biotechnology activity in New Zealand conducted by Statistics New Zealand in 2000. The …
Persistent link: https://www.econbiz.de/10005634985
This paper examines the effect of foreign direct investment (FDI) on domestic innovation based on a data set covering the pharmaceutical industries across 29 provinces in the People's Republic of China (PRC) over the period 1998-2007. We show that there is a negative horizontal spillover effect...
Persistent link: https://www.econbiz.de/10011723712
Taking into account the relevance of Biotechnology in the World industry and economic growth, this essay is focused on … on Biotechnology. An example of the use of patent information for determining trends by means of Technology Surveillance …
Persistent link: https://www.econbiz.de/10013100742
We have examined all the US patents (444) issued to homegrown Indian pharma and pharma biotech firms. Most (425, 95%) patents are pharma patents not biotech (19). Also, only 11 patents have been cited ten times or more. This data provides one snapshot of the biotech industry in India today. It...
Persistent link: https://www.econbiz.de/10014129813
This paper provides a detailed description of the New Zealand biotechnology sector based on a re-analysis of the first … comprehensive (1998/99) survey of biotechnology in New Zealand, data from an original (2002) survey conducted by the author and a …
Persistent link: https://www.econbiz.de/10005634988
This paper sheds light on factors influencing to what extent MNCs are able to implement a global environmental strategy. We apply the concept of absorptive capacity to analyze what role the uptake and integration of external knowledge playsin implementing an environmental strategy and propose to...
Persistent link: https://www.econbiz.de/10013153553
We examine the role of spillover learning in shaping the value of exploratory versus incremental R&D. Using data from drug development, we show that novel drug candidates generate more knowledge spillovers than incremental ones. Despite being less likely to reach regulatory approval, they are...
Persistent link: https://www.econbiz.de/10014287391
Information about the success of a new technology is usually held asymmetrically between the research and development (R&D)-performing firm and potential lenders and investors. This raises the cost of capital for financing R&D externally, resulting in financing constraints on R&D especially for...
Persistent link: https://www.econbiz.de/10010341887